IP Library Granted Patent US 7,651,680
Granted Patent B2
US 7,651,680 · App. 11/159,198 · Granted Jan 26, 2010

Methods and compositions for preventing and treating sensitive and dry skin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,651,680
App. No.
11/159,198
Granted
Jan 26, 2010
Kind
B2
Abstract

Compositions for preventing and/or treating sensitive and/or dry skin include at least an effective amount of at least one agent and at least an effective amount of at least one divalent inorganic cation, wherein the at least one agent includes at least one member selected from the group consisting of at least one microorganism, a fraction of the at least one microorganism and a metabolite of the at least one microorganism. Methods for preparing such compositions and cosmetic treatment methods employing such compositions are also provided.

Claims (40)

1. A cosmetic treatment method for at least one of preventing and treating at least one of sensitive skin and dry skin, comprising:

orally administering to a human a composition comprising at least an effective amount of at least one agent and at least an effective amount of at least one divalent inorganic cation;

wherein:

the at least one agent comprises at least one member selected from the group consisting of at least one microorganism, a fraction of the at least one microorganism and a metabolite of the at least one microorganism;

said at least one microorganism comprises at least one lactic acid bacterium selected from the genus Bifidobacterium;

said at least one microrganism further comprises at least one lactic acid bacterium selected from the genus Lactobacillus sp;

the at least one divalent inorganic cation comprises at least one salt selected from the group consisting of a magnesium salt and a calcium salt;

said at least one divalent inorganic cation is administered at a rate of about 1 to about 3000 mg per day; and

said at least one agent is administered at a rate of about 5×10 5 to about 10 13 cfu per day.

2. The cosmetic treatment method of claim 1 , wherein the at least one divalent inorganic cation is in the form of a salt other than a sulfate.

3. The cosmetic treatment method of claim 1 , wherein the at least one divalent inorganic cation is in the form of at least one of an anhydrous organic salt, a hydrated organic salt and a chelated complex.

4. The cosmetic treatment method of claim 1 , wherein the at least one agent is formulated in a physiologically acceptable carrier in an amount equivalent to at least 10 3 cfu/g.

5. The cosmetic treatment method of claim 1 , wherein the at least one divalent inorganic cation comprises at least two different divalent inorganic cations.

6. The cosmetic treatment method of claim 5 , wherein the at least one divalent inorganic cation comprises an alkaline earth metal.

7. The cosmetic treatment method of claim 6 , wherein the alkaline earth metal comprises at least one member selected from the group consisting of barium, calcium, magnesium, strontium and beryllium.

8. The cosmetic treatment method of claim 1 , wherein the at least one divalent inorganic cation is in the form of at least one salt selected from the group consisting of a carbonate, a bicarbonate, a gluconate, a glycerophosphate, a chloride, a nitrate, an acetate, a hydroxide, an oxide, an α-hydroxy acid salt, a salt of a fruit acid, an amino acid salt and a fatty acid salt.

9. The cosmetic treatment method of claim 8 , wherein the α-hydroxy acid salt comprises at least one member selected from the group consisting of a citrate, a tartrate, a lactate and a malate.

10. The cosmetic treatment method of claim 8 , wherein the amino acid salt comprises at least one member selected from the group consisting of an aspartate, an arginate and a fumarate.

11. The cosmetic treatment method of claim 8 , wherein the fatty acid salt comprises at least one member selected from the group consisting of a palmitate, an oleate, a caseinate and a behenate.

12. The cosmetic treatment method of claim 1 , wherein the at least one divalent inorganic cation is in the form of at least one salt selected from the group consisting of a calcium gluconate, a calcium citrate, a calcium lactate, a calcium chloride, a calcium acetate, a magnesium gluconate, a magnesium citrate, a magnesium lactate, a magnesium chloride and a magnesium acetate.

13. The cosmetic treatment method of claim 1 , wherein the composition is in the form of a cosmetic composition.

14. The cosmetic treatment method of claim 1 , wherein said at least one microorganism comprises Bifidobacterium adolescentis (CNCM I-2168).

15. The cosmetic treatment method of claim 1 , wherein said at least one microorganism comprises Bifidobacterium longum (CNCM I-2170).

16. The cosmetic treatment method of claim 1 , wherein said at least one microorganism comprises Bifidobacterium lactis (CNCM I-3446).

17. The cosmetic treatment method of claim 1 , wherein said at least one microorganism comprises Bifidobacterium longum (BB536).

18. A cosmetic treatment method for at least one of preventing and treating at least one of sensitive skin and dry skin, comprising:

at least one of orally and topically administering to a human a composition comprising at least an effective amount of at least one agent and at least an effective amount of at least one divalent inorganic cation;

wherein:

the at least one agent comprises at least one member selected from the group consisting of at least one microorganism, a fraction of the at least one microorganism and a metabolite of the at least one microorganism;

said at least one agent is administered at a rate of about 5×10 5 to about 10 13 cfu per day;

the at least one divalent inorganic cation is in the form of a salt other than a sulfate;

the at least one divalent inorganic cation comprises at least one salt selected from the group consisting of a magnesium salt and a calcium salt;

said at least one divalent inorganic cation is administered at a rate of about 1 to about 3000 mg per day;

said at least one microorganism comprises at least one lactic acid bacterium selected from the genus Bifidobacterium ; and

said at least one microrganism further comprises at least one lactic acid bacterium selected from the genus Lactobacillus sp.

19. The cosmetic treatment method of claim 18 , wherein the orally administered composition is in a form of a food composition.

20. The cosmetic treatment method of claim 18 , wherein said at least one microorganism comprises Bifidobacterium adolescentis (CNCM I-2168).

21. The cosmetic treatment method of claim 18 , wherein said at least one microorganism comprises Bifidobacterium longum (CNCM I-2170).

22. The cosmetic treatment method of claim 18 , wherein said at least one microorganism comprises Bifidobacterium lactis (CNCM I-3446).

23. The cosmetic treatment method of claim 18 , wherein said at least one microorganism comprises Bifidobacterium longum (BB536).

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2006
From: BRETON, LIONEL; JOURDAIN, ROLAND; GUENICHE, AUDREY; BUREAU-FRANZ, ISABELLE; BLUM-SPERISEN, STEPHANIE
To: L'OREAL; NESTEC S.A.
Reel/Frame 017161/0074 →